Skip navigation

Our lymphoma research

Lymphomas are cancers that develop from cells of the lymphatic system. Non-Hodgkin's lymphomas make up over four in five lymphomasLymphoma is a type of cancer that affects cells in the lymphatic system - the network of lymph glands and vessels that helps to protect us from infection. 

Thanks to improved treatments, survival from lymphoma has significantly increased over the past thirty years. For example, more than 6 out of ten younger patients with non-Hodgkin lymphoma will survive for five years or more.

There is information for people affected by Hodgkin's and non-Hodgkin lymphoma on our CancerHelp UK site. 

Below are some of the highlights of our lymphoma research. Visit MyProjects to donate directly to our research into non-Hodgkin lymphoma.

Cell death (apoptosis)

Prof Peter Johnson Prof Peter Johnson

Cancer Research UK Medical Oncology Unit

University of Southampton, Southampton

Developing new cancer treatments

Professor Peter Johnson is the Cancer Research UK's Chief Clinician, and directs the Southampton Cancer Research UK Centre. He is helping to shape the future of our clinical research across the UK. Professor Johnson is a leading expert in lymphoma - a cancer that affects the body's white blood cells. He's also working on new treatments that use the power of the body's own immune system to attack tumours.

Chemotherapy

Dr Simon Rule Dr Simon Rule

Derriford Hospital

Plymouth Hospitals NHS Trust, Plymouth

Investigating new treatments for lymphoma

Dr Simon Rule is researching new treatments for lymphoma, a cancer of the white blood cells. His team are carrying out a clinical trial looking at treatments for a rare but aggressive form of the disease called mantle cell lymphoma.

Clinical trials

Professor Andrew Pettitt Professor Andrew Pettitt

Department of Haematology, School of Cancer Studies

University of Liverpool, Liverpool

Improving treatment for lymphoma

Professor Andrew Pettitt is a leading expert on leukaemia and lymphoma at the University of Liverpool. He is researching ways to improve treatments for these diseases, and is part of the Liverpool Cancer Research UK Centre.

Dr Simon Rule Dr Simon Rule

Derriford Hospital

Plymouth Hospitals NHS Trust, Plymouth

Investigating new treatments for lymphoma

Dr Simon Rule is researching new treatments for lymphoma, a cancer of the white blood cells. His team are carrying out a clinical trial looking at treatments for a rare but aggressive form of the disease called mantle cell lymphoma.

Dr Hamish Wallace Dr Hamish Wallace

Royal Hospital for Sick Children

University of Edinburgh, Edinburgh

Improving treatment for Hodgkin’s lymphoma

Dr Hamish Wallace is based at the Royal Hospital for Sick Children in Edinburgh, where he is running an international clinical trial to improve treatment for young people with Hodgkin's lymphoma.

Epstein Barr virus (EBV)

Prof Alan Rickinson Prof Alan Rickinson

School of Cancer Sciences

University of Birmingham, Birmingham

Understanding viruses that cause cancer

Professor Alan Rickinson is a world expert on the Epstein-Barr virus (EBV). This virus is linked to certain types of cancer including Hodgkin's lymphoma and Burkitt's lymphoma - cancers that arise from cells of the immune system. 

Prof Lawrence Young Prof Lawrence Young

School of Cancer Sciences

University of Birmingham, Birmingham

Understanding viruses that cause cancer

Professor Lawrence Young is Head of College of Medical and Dental Sciences at the University of Birmingham. Together with his team, he is investigating how Epstein-Barr virus (EBV) infection is linked to certain types of cancer including Hodgkin's lymphoma and nasopharyngeal cancer

Immunotherapy

Prof Peter Johnson Prof Peter Johnson

Cancer Research UK Medical Oncology Unit

University of Southampton, Southampton

Developing new cancer treatments

Professor Peter Johnson is the Cancer Research UK's Chief Clinician, and directs the Southampton Cancer Research UK Centre. He is helping to shape the future of our clinical research across the UK. Professor Johnson is a leading expert in lymphoma - a cancer that affects the body's white blood cells. He's also working on new treatments that use the power of the body's own immune system to attack tumours.

Prof Christian Ottensmeier Prof Christian Ottensmeier

Cancer Sciences Division, School of Medicine

University of Southampton, Southampton

Cancer vaccines - harnessing the immune system to fight cancer

Professor Christian Ottensmeier and his team based at Southampton General Hospital are at the forefront of research into cancer vaccines. This novel approach to cancer treatment aims to stimulate the body's own immune system to recognise and kill the cancer cells. The technique is being tested as a treatment for cancers such as lymphoma and myeloma.